MedTrace Logo

Natural Progesterone and Preterm Birth in Twins

NCT00480402 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2013-04-04

No results posted yet for this study

Summary

To assess the effectiveness of natural progesterone supplementation in preventing preterm births in twins.

Conditions

Interventions

DRUG

200 mg of Progesterone

Administration of 200 mg of Progesterone

DRUG

400 mg Progesterone

Administration of 400 mg Progesterone

DRUG

Placebo

Administration of a Placebo

Sponsors & Collaborators

  • Instituto Valenciano de Infertilidad, IVI VALENCIA

    lead OTHER

Principal Investigators

  • Vicente Serra, MDPhD · Instituto Valenciano de la Infertilidad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00480402 on ClinicalTrials.gov